An HIV Vaccine for South-East Asia-Opportunities and Challenges

Vaccines
Punnee PitisuttithumJean-Louis Excler

Abstract

Recent advances in HIV vaccine development along with a better understanding of the immune correlates of risk have emerged from the RV144 efficacy trial conducted in Thailand. Epidemiological data suggest that CRF01_AE is still predominant in South-East Asia and is spreading in China with a growing number of circulating recombinant forms due to increasing human contact, particularly in large urban centers, tourist locations and in sites of common infrastructure. A vaccine countering CRF01_AE is a priority for the region. An Asia HIV vaccine against expanding B/E or BCE recombinant forms should be actively pursued. A major challenge that remains is the conduct of efficacy trials in heterosexual populations in this region. Men who have sex with men represent the main target population for future efficacy trials in Asia. Coupling HIV vaccines with other prevention modalities in efficacy trials might also be envisaged. These new avenues will only be made possible through the conduct of large-scale efficacy trials, interdisciplinary teams, international collaborations, and strong political and community commitments.

References

Nov 17, 2006·The Journal of Infectious Diseases·Punnee PitisuttithumUNKNOWN Bangkok Vaccine Evaluation Group
Oct 4, 2007·PloS One·Sven LétourneauTomás Hanke
Nov 7, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Heather B JaspanUNKNOWN HIV Vaccine Adolescent Trials Working Group
Mar 18, 2008·Conflict and Health·Brian WilliamsCharles Petrie
Nov 13, 2008·AIDS Research and Human Retroviruses·Benjamin SilbermannOdile Launay
Jan 31, 2009·The Lancet Infectious Diseases·Marie-Claude BoilyMichel Alary
Apr 22, 2009·AIDS·Narat Punyacharoensin, Chukiat Viwatwongkasem
Jun 13, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J H K ChenW C Yam
Jun 17, 2009·The New England Journal of Medicine·Michelle M Mello, Troyen A Brennan
Jul 23, 2009·AIDS Research and Human Retroviruses·Ivo N SahbandarShigehiro Sato
Feb 26, 2010·Sexually Transmitted Diseases·Haitao YangJoseph T F Lau
Apr 9, 2010·Journal of Virology·Katharine J BarGeorge M Shaw
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Victor DeGruttolaVeronica Miller
Apr 27, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lesley S ParkChaiyos Kunanusont
Jun 1, 2010·Vaccine·Punnee PitisuttithumSupachai Rerk-Ngnam
Jun 10, 2010·AIDS Research and Human Retroviruses·Lin LiJingyun Li
Jul 14, 2010·Journal of the International AIDS Society·Susan C KimMark R Dybul
Jul 20, 2010·JAMA : the Journal of the American Medical Association·Cristine J CooperUNKNOWN NIAID HIV Vaccine Trials Network (HVTN) Vaccine-Induced Seropositivity (VISP) Task Force
Jul 30, 2010·AIDS and Behavior·Chyvette T WilliamsJudith A Levy
Sep 30, 2010·PLoS Medicine·Stephen J KentUNKNOWN AIDS Vaccine for Asia Network investigators and supporters
Oct 15, 2010·AIDS·Frits van Griensven, Jan W de Lind van Wijngaarden
Oct 28, 2010·Current Opinion in HIV and AIDS·Jerome H KimNelson L Michael
Nov 4, 2010·AIDS Research and Human Retroviruses·Jean-Louis ExclerPatricia Fast
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Nov 26, 2010·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Janin NouhinNicole Ngo-Giang-Huong
Feb 8, 2011·AIDS·Joris HemelaarUNKNOWN WHO-UNAIDS Network for HIV Isolation and Characterisation
Feb 9, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Eva Van BraeckelGeert Leroux-Roels
Apr 15, 2011·AIDS Research and Treatment·John StoverCarlos Avila
Jun 7, 2011·Lancet·Bernhard SchwartländerUNKNOWN Investment Framework Study Group
Jun 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nancy S PadianStefano M Bertozzi

❮ Previous
Next ❯

Citations

Aug 29, 2014·Expert Review of Vaccines·Robert J O'ConnellJean-Louis Excler
Jun 13, 2014·Clinical and Vaccine Immunology : CVI·Jean-Louis ExclerStanley A Plotkin
Dec 5, 2020·Social Work in Public Health·Maria Dyah KurniasariCheng-Wen Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Vaccines
Sorachai NitayaphanJean-Louis Excler
AIDS Research and Human Retroviruses
Nittaya PhanuphakJean Louis Excler
Expert Opinion on Biological Therapy
Sandhya Vasan, Nelson L Michael
Current Opinion in HIV and AIDS
Erica Andersen-NissenM Juliana McElrath
© 2021 Meta ULC. All rights reserved